Lee S Cohen

Array ( [id] => 6896408 [patent_doc_number] => 20010027198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Novel heterocyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them' [patent_app_type] => new [patent_app_number] => 09/818339 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24483 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20010027198.pdf [firstpage_image] =>[orig_patent_app_number] => 09818339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1337669 [patent_doc_number] => 06593333 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Substituted anilino-quinazoline (or quinoline) compounds and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/787883 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34240 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593333.pdf [firstpage_image] =>[orig_patent_app_number] => 09787883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440332 [patent_doc_number] => 06495557 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Condensed thienopyrimidines with phosphodiesterase-v inhibiting action' [patent_app_type] => B1 [patent_app_number] => 09/674269 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4669 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495557.pdf [firstpage_image] =>[orig_patent_app_number] => 09674269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065547 [patent_doc_number] => 20010044435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them' [patent_app_type] => new [patent_app_number] => 09/816003 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16673 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044435.pdf [firstpage_image] =>[orig_patent_app_number] => 09816003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065814 [patent_doc_number] => 20010044540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors' [patent_app_type] => new [patent_app_number] => 09/814573 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8673 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044540.pdf [firstpage_image] =>[orig_patent_app_number] => 09814573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082583 [patent_doc_number] => 20020082268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof' [patent_app_type] => new [patent_app_number] => 09/813096 [patent_app_country] => US [patent_app_date] => 2001-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23364 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082268.pdf [firstpage_image] =>[orig_patent_app_number] => 09813096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6885179 [patent_doc_number] => 20010039343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'Process to intermediates for biologically active compounds' [patent_app_type] => new [patent_app_number] => 09/804704 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31647 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20010039343.pdf [firstpage_image] =>[orig_patent_app_number] => 09804704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1566812 [patent_doc_number] => 06376500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-04-23 [patent_title] => 'Substituted 2-(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones' [patent_app_type] => B2 [patent_app_number] => 09/803078 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14311 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376500.pdf [firstpage_image] =>[orig_patent_app_number] => 09803078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065751 [patent_doc_number] => 20010044534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Pyrimidine derivative salt' [patent_app_type] => new [patent_app_number] => 09/799097 [patent_app_country] => US [patent_app_date] => 2001-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2722 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044534.pdf [firstpage_image] =>[orig_patent_app_number] => 09799097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342543 [patent_doc_number] => 06590107 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides' [patent_app_type] => B1 [patent_app_number] => 09/799327 [patent_app_country] => US [patent_app_date] => 2001-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13981 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/590/06590107.pdf [firstpage_image] =>[orig_patent_app_number] => 09799327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1224103 [patent_doc_number] => 06699855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-02 [patent_title] => 'Inhibitors of hepatitis C virus NS3 protease' [patent_app_type] => B2 [patent_app_number] => 09/795410 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40460 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3368 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699855.pdf [firstpage_image] =>[orig_patent_app_number] => 09795410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889584 [patent_doc_number] => 20010025039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Aza- indolyl derivatives for treating obesity' [patent_app_type] => new [patent_app_number] => 09/794491 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9924 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20010025039.pdf [firstpage_image] =>[orig_patent_app_number] => 09794491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1378200 [patent_doc_number] => 06559152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-06 [patent_title] => '6-substituted pyrazolo3,4-dpyrimidin-4-ones useful as cyclin dependent kinase inhibitors' [patent_app_type] => B2 [patent_app_number] => 09/794825 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33823 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559152.pdf [firstpage_image] =>[orig_patent_app_number] => 09794825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065561 [patent_doc_number] => 20010044440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Modulators of p38 MAP kinase' [patent_app_type] => new [patent_app_number] => 09/792876 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2006 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044440.pdf [firstpage_image] =>[orig_patent_app_number] => 09792876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291814 [patent_doc_number] => 20020055514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'JAK-3 inhibitors for treating allergic disorders' [patent_app_type] => new [patent_app_number] => 09/791040 [patent_app_country] => US [patent_app_date] => 2001-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20129 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055514.pdf [firstpage_image] =>[orig_patent_app_number] => 09791040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6896406 [patent_doc_number] => 20010027196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Adenosine receptor ligands and their use in the treatment of disease' [patent_app_type] => new [patent_app_number] => 09/788956 [patent_app_country] => US [patent_app_date] => 2001-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85646 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20010027196.pdf [firstpage_image] =>[orig_patent_app_number] => 09788956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365773 [patent_doc_number] => 06570013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-27 [patent_title] => 'Salts of zopolrestat' [patent_app_type] => B2 [patent_app_number] => 09/782798 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32517 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/570/06570013.pdf [firstpage_image] =>[orig_patent_app_number] => 09782798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278745 [patent_doc_number] => 20020107252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Novel Compounds' [patent_app_type] => new [patent_app_number] => 09/868884 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18473 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107252.pdf [firstpage_image] =>[orig_patent_app_number] => 09868884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460030 [patent_doc_number] => 06391882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => '4,5,6 and 7-indole and indoline derivatitives, their preparation and use' [patent_app_type] => B1 [patent_app_number] => 09/719849 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14040 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 860 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391882.pdf [firstpage_image] =>[orig_patent_app_number] => 09719849 [rel_patent_id] =>[rel_patent_doc_number] =>)